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Abstract
Bisphenol-A is an important environmental contaminant due to the increased early-life exposure that may pose significant
health-risks to various organisms including humans. This study aimed to use zebrafish as a toxicogenomic model to capture
transcriptomic and phenotypic changes for inference of signaling pathways, biological processes, physiological systems and
identify potential biomarker genes that are affected by early-life exposure to bisphenol-A. Phenotypic analysis using wild-
type zebrafish larvae revealed BPA early-life exposure toxicity caused cardiac edema, cranio-facial abnormality, failure of
swimbladder inflation and poor tactile response. Fluorescent imaging analysis using three transgenic lines revealed
suppressed neuron branching from the spinal cord, abnormal development of neuromast cells, and suppressed
vascularization in the abdominal region. Using knowledge-based data mining algorithms, transcriptome analysis suggests
that several signaling pathways involving ephrin receptor, clathrin-mediated endocytosis, synaptic long-term potentiation,
axonal guidance, vascular endothelial growth factor, integrin and tight junction were deregulated. Physiological systems
with related disorders associated with the nervous, cardiovascular, skeletal-muscular, blood and reproductive systems were
implicated, hence corroborated with the phenotypic analysis. Further analysis identified a common set of BPA-targeted
genes and revealed a plausible mechanism involving disruption of endocrine-regulated genes and processes in known
susceptible tissue-organs. The expression of 28 genes were validated in a separate experiment using quantitative real-time
PCR and 6 genes, ncl1, apoeb, mdm1, mycl1b, sp4, U1SNRNPBP homolog, were found to be sensitive and robust biomarkers
for BPA early-life exposure toxicity. The susceptibility of sp4 to BPA perturbation suggests its role in altering brain
development, function and subsequently behavior observed in laboratory animals exposed to BPA during early life, which is
a health-risk concern of early life exposure in humans. The present study further established zebrafish as a model for
toxicogenomic inference of early-life chemical exposure toxicity.
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Introduction
Bisphenol-A (BPA) used in the manufacture of polycarbonate
plastic and epoxy resin is among the highest-production-volume
chemicals in the world [1]. It is an important contaminant due to
its ubiquitous presence and the increased exposure of humans and
organisms to BPA via environment and food chain. The concern
on the ecological impact of BPA has been increasingly raised in the
past few years as more studies reveal ontogenetic and endocrine
disruptions by BPA on aquatic organisms at environmental
relevant concentrations [2,3]. In line with this concern are the
controversies due to conflicting reports and equivocal findings
regarding potential human health effects of early-life exposure to
BPA [4–6] at the level similar to those used in rodent studies, in
which neuro-developmental effects, defect in reproductive tissue
development, and predisposition to preneoplastic lesions of the
mammary gland and prostate gland in adult life have been
reported [7–11]. Although there had been many BPA studies
involving rodents including several well-designed multi-generation
studies [6,7], there is still limited in vivo toxicogenomic information
on BPA-induced toxicity during early life. This may be partly due
to the protracted in utero development of rodents which restrict
accessibility and experimental manipulation.
The zebrafish is a premier model for both developmental [12]
and toxicological [13] studies. It is also increasingly used for
modeling human diseases [14] and for pre-clinical drug screening
[15]. The availability of zebrafish in large numbers, its small size
and easy husbandry makes the zebrafish a more cost-effective
model than the rodent models for toxicological studies. This is
important in view that there is a great demand for cost-effective
and ethically acceptable approaches to evaluate the toxicity of
pharmaceuticals, industrial chemicals and effluents by regulators
and industry, and there are strong advocates for using zebrafish to
reduce the use of rodent models for such purposes [16,17].
Presently, zebrafish embryo is included as one of the principal test
organism within the Organization for Economic Cooperation and
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[18]. BPA is an endocrine disruptor and the aquatic environment
is a major sink of BPA due to leaching from plastic debris, landfill
wastes and sewage effluent [2,3], thus making zebrafish a relevant
model for investigating BPA toxicity.
Owing to the conserved developmental program within
vertebrates, fish and mammals share many similar developmental
processes. Many of the genes or molecules with essential functions
found in humans such as those involved in developmental
processes and toxicological responses are also found in zebrafish.
We and others have shown that zebrafish is responsive to
chemicals, such as small molecules, drugs and environmental
toxicants, in a similar manner as mammals [19–23]. Consequent-
ly, zebrafish is also susceptible to chemical-induced pathology
similar to those observed in mammals [22,24]. The availability of
many zebrafish transgenic and enhancer trap lines with fluorescent
reporter genes expressed in specific tissues/organs could help in
visualizing and real-time monitoring of chemical-induced toxicity
changes in live animals [25]. In addition, the amenability of the
zebrafish system to various molecular techniques and the vast
genomic resources, including the near-completed zebrafish
genome project and availability of zebrafish microarrays, makes
zebrafish a highly versatile system for toxicogenomic studies
[26,27].
Previously, we have demonstrated that transcriptomic data
generated from whole-adult zebrafish, despite loss of weak signals
and loss of signal response location, is able to capture strong and
well-represented expression signals that are sufficiently robust for
predictive chemical biology, for discovering biomarkers and major
signaling pathways, as well as useful for human health-risk and
biological insight inference [19]. In this study, we applied a similar
approach on whole zebrafish larvae to capture strong and well-
represented expression signals affected by early-life exposure to
BPA. We performed toxicogenomic analysis with the aim of
inferring signaling pathways, biological processes, physiological
systems and potential biomarkers that may be affected by early-life
exposure to BPA in zebrafish. We corroborated the toxicogenomic
inferences with phenotypic end-points in wild-type and specific
transgenic lines. We further identified a common set of BPA
affected genes and performed a focused knowledge-based
connectivity network analysis to derive plausible mechanistic
insights of BPA early-life exposure toxicity. Finally, we carried out
an independent validation experiment by treating new batches of
developing zebrafish and validated 28 genes via real-time
quantitative PCR whereby 6 were found to be sensitive and
robust, hence potentially good biomarkers for BPA early-life
exposure toxicity. We found sp4 which encodes a transcription
factor to be susceptible to BPA perturbation and may account for
the altered brain development, function and subsequently
behavior observed in laboratory animals exposed to BPA during
early life. This study demonstrated the potential of using zebrafish
as a model for toxicogenomic inference of early-life exposure
toxicity through BPA-induced cumulative phenotype and tran-
scriptome analyses.
Results and Discussion
Phenotypic analysis of BPA early-life exposure toxicity in
wild-type zebrafish
Developing zebrafish were exposed to nominal concentration of
50, 100, 500, 1500 and 4500 mg/L BPA (0.22 mM to 19.71 mM)
with final concentration 0.05% (v/v) ethanol (vehicle) in egg water
for 7 days from 3 hours post-fertilization (hpf) onwards. Control
fish were maintained in egg water with vehicle alone and media
was renewed daily. The chosen BPA concentrations spanned from
environmental-relevant high concentrations (.1000 mg/L) found
in landfill leachate and sewage treatment effluent sources [2,3] to
the range of a recent proposed total allowable concentration
(100 mg/L) for drinking water [1]. This embryo-larval 7-day static
renewal test, adopted from short term methods for estimating
chronic toxicity in freshwater organisms [28], allows for
assessment of the cumulative adverse teratogenic effects of
chemical(s) on the development and physiology of the organism
during early life.
In a total of four experimental replicates, statistically significant
mortality (Figure 1A) and cardiac edema (Figure 1B) were
observed in developing zebrafish larvae treated with 1500 and
4500 mg/L BPA when compared to control (vehicle) group (T-test
P,0.05; each treatment group consists of 50 embryos and the
experiment was repeated four times; n=4). No statistically
significant (T-test P.0.05) adverse effects were observed in
developing zebrafish treated with BPA at 500 mg/L or lower. In
addition, fish with cardiac edema also appeared to have cranio-
facial abnormality [broad-headed (brachycephalic) and lacks
anterior lower jaw protrusion], problems with swimbladder
development/inflation and apparent gastro-intestinal abnormali-
ties and partial yolk-sac re-absorption (Figure 1C–H), resembling
those that we [29] and others [30] have reported previously in
thyroid hormone studies using developing zebrafish. Fish with
‘curved-tail-down’ phenotype occurring at higher concentration of
BPA suggesting neuro-muscular problem as previously reported
[31,32] were occasionally observed (1–2%) at 1500 and 4500 mg/
L BPA (not shown). Fish treated with 1500 and 4500 mg/L BPA
appeared to be ‘listless’ (poor tactile response) and some exhibited
abnormal swimming behavior that are likely associated with
swimbladder and/or neuro-muscular problems.
Phenotypic analysis of BPA early-life exposure toxicity in
transgenic zebrafish
To help better visualize and assess some of the changes in
specific tissue-organs as a result of early-life exposure to BPA, we
also employed three transgenic lines [Tg(Nkx2.2a-mEGFP), Tg(Flia-
EGFP)
y1, and ET(krt8-EGFP)
sqet20; see Table S1 for information on
the transgenic lines]. However, the transgenic lines appeared to be
more sensitive to BPA toxicity as the fish succumbed to BPA at a
higher rate (data not shown) compared to the wild-type fish.
Hence after preliminary assay optimization, we exposed the fish to
50, 500 and 5000 mg/L BPA for 5 days. Interestingly, Tg(Nkx2.2a-
mEGFP) revealed that dorsal and ventral growth and branching of
axons from the spinal cord were inhibited in fish treated with
5000 mg/L but mildly suppressed in fish treated with 500 mg/L
(Figure 2A). Similar inhibition of axon growth and branching has
been observed in Tg(Nkx2.2a-mEGFP) line treated with 17-beta
estradiol but not with mefenamic acid (a non-steroidal anti-
inflammatory drug) (Figure S1) suggesting specific estrogenic
neurotoxicity. The findings further suggest that the development of
the central nervous system, especially the later stages involving
growth and branching of axons, is sensitive to BPA toxicity and
this may be related to BPA estrogenic activity although we could
not exclude other mode of neurotoxicity that can induce similar
phenotype. The ET(krt4-EGFP)
sqet20 showed that neuromast cells
along the lateral line which normally appeared in a rosette-like
circular shape in control fish were deformed with irregular shape
in fish exposed to 500 mg/L and 5000 mg/L BPA (Figure 2B)
suggesting that the neuro-sensory system is affected in these fish. In
addition, Tg(Flia-EGFP)
y1 further revealed that vascularization in
the abdominal region (swimbladder and of the gastro-intestinal
region) were also suppressed in a dose-dependent manner at 500
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PLoS ONE | www.plosone.org 2 December 2011 | Volume 6 | Issue 12 | e28273Figure 1. Phenotype analysis of BPA early-life exposure toxicity in wild-type zebrafish larvae. (A) Percentage of mortality and (B)
percentage of larvae with edema when developing zebrafish were exposed to BPA at 50, 100, 500, 1500 and 4500 mg/L BPA or vehicle control for 7
days from 3 hour post-fertilization (hpf) onwards. Error bars represent mean 6 SD. Asterisk indicate significant (P,0.05) differences when compared
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BPA caused dose-dependent adverse effects as a result of early-life
exposure toxicity in transgenic zebrafish exposed to 500 mg/L and
5000 mg/L but no apparent adverse abnormalities were observed
in transgenic fish exposed to 50 mg/L of BPA in all experiments
(data not shown). The ability to observe phenotypic abnormalities
easily is an advantage of the zebrafish model and these
abnormalities would provide corroboration as ‘phenotypic-an-
choring’ points [33] for subsequent transcriptome analysis into
BPA early-life exposure toxicity.
Microarray data analysis of BPA early-life exposure
toxicity in wild-type zebrafish
To determine the levels of toxicity of BPA used for microarray
experiments, zebrafish fry were also exposed to higher concentra-
tions of BPA and we estimated that the LC50 is around 8.6 mg/L
under our conditions (Figure 1A inset). Based on the dose-
dependent phenotypic effect observed in wild-type and transgenic
zebrafish, BPA concentrations of 500 mg/L, 1500 mg/L and
4500 mg/L (corresponding to LC5 to LC15) were used for the
microarray experiment to obtain toxicogenomic information for
inferring signaling pathways, biological processes, physiological
systems and potential biomarkers that may be affected by early-life
exposure to BPA toxicity in zebrafish. Similar experimental design
and conditions were employed; 50 larvae were pooled for one
biological replicate and the experiment was repeated several times
in order to obtain sufficient materials for 4–5 biological replicates
used in the microarray hybridization.
Microarray data from a total of 18 arrays, consisting of 5
biological replicate arrays for each control and 500 mg/L groups
and 4 biological replicate arrays for each 1500 mg/L and
4500 mg/L groups, were used for subsequent transcriptome
analysis. The transcriptome data were subjected to Lowess
normalization followed by One-Way ANOVA. After One-Way
ANOVA and False Discovery Rate (FDR) adjustment (see
Materials and Methods), a total of 1119 genes (with unique
GenBank ID) were found to have less than 20% FDR. Subsequent
t-test between each treatment group and the control group yielded
358, 696 and 594 genes considered as significantly (ANOVA
FDR,20% and T-test P,0.05) deregulated within the respective
treatment groups of 500, 1500 and 4500 mg/L BPA when
compared to control group (Figure 3A). The number of
deregulated genes increased by two-fold between 500–1500 mg/
L suggesting a BPA concentration-dependent response, followed
by a slight decrease (,15%) in the 4500 mg/L group suggesting an
onset BPA-induced toxicity affecting gene expression. After
accounting for overlapping genes, we found that 73 genes (6.5%
of 1119 genes) were significantly deregulated in all three treatment
groups while 383 (34.2%) genes were found to be significant in two
treatment groups and 663 (59.3%) genes were only significant in
one of the treatment group (Figure 3A). Even so, it is worth
mentioning that majority of these genes demonstrated mean
expression profiles that are consistently up- or down-regulated
(although may not be statistically significant) or in a concentration-
dependent response trend in all the three BPA concentrations
when compared to the control group (Figure 3B). It is also
noteworthy that the levels of vitellogenin1 (vtg1) mRNAs was up-
regulated 2-fold (p-value=0.08) at 4500 mg/L BPA and vitello-
genin3 (vtg3) mRNAs was significantly (p-value,0.05) up-regulated
2.3-fold and 3.4-fold at 1500 mg/L and 4500 mg/L BPA,
respectively, when compared to the control group (data not
shown). This confirms that our microarray data were able to
capture significant estrogenic effects as indicated by the induction
of vitellogenin mRNAs. Our data corroborated with the study by
Muncke et al [34] which reported up to 50-fold induction of vtg1
mRNAs by BPA by using a more sensitive real-time PCR assay.
Independent validation of microarray data and
identification of potential biomarkers
In order to validate the microarray data and identify potential
biomarkers for BPA early-life exposure toxicity, we conducted an
independent validation experiment by treating new batches of
developing zebrafish similar to the earlier acute toxicity experi-
ment (n=5–6 biological replicates; each biological replicate
consists of five pooled larvae). Total RNA was extracted from
the pooled larvae of each treatment group and reverse-transcribed
to cDNA for real-time PCR validation of 28 genes selected from
those that were significant in 2–3 treatment groups. In general, the
PCR data showed good concordance with the microarray data in
terms of the expression direction (up- or down-regulation)
although the fold-change levels of genes compared to their
respective controls were not always similar between the PCR and
microarray data (Figure 4 and 5). Nevertheless, they served to
validate the expression pattern of these genes captured by the
microarray experiment. This further provides greater confidence
of the subsequent transcriptome analysis,
Among the 28 validated genes (16 up-regulated; 12 down-
regulated), 16 were deregulated (T-test P,0.10), including 6 (ncl1,
apoeb, mdm1, mycl1b, sp4, U1SNRNPBP homolog) that were up-
regulated and 2 (got2b, mdkb) that were down-regulated significantly
(T-test P,0.05), in at least 4 concentration groups. The remaining
12 genes were deregulated (P,0.10) in 2–3 concentration groups.
There were also 12 genes that were deregulated (P,0.10),
including 8 (ncl1, apoeb, mdm1, mycl1b, U1SNRNPBP homolog,
atp5f1, csrp2bp, ZNF384 homolog) which were significantly
(P,0.05) up-regulated, in both 50 and 100 mg/L BPA. Based on
these findings, we proposed 6 genes, ncl1, apoeb, mdm1, mycl1b, sp4,
U1SNRNPBP homolog, which were up-regulated in at least 4
concentration groups (P,0.05) as well as in both 50 and 100 mg/L
BPA (P,0.10) to be sensitive and robust biomarkers for BPA
early-life exposure toxicity. It is noteworthy that these 6 genes are
deregulated within the proposed total allowable concentration
(100 mg/L) of BPA for drinking water [1].
These six genes were further tested under similar experimental
regime using 17-beta estradiol and mefenamic acid. We found that
all the six genes showed good concordance in terms of statistical
significance (p-value,0.1) in the up-regulation trend between
samples treated with 17-beta estradiol and BPA at similar
concentrations. In fry treated with mefenamic acid at similar
concentrations, only three genes (ncl1, sp4, U1SNRNPBP homolog)
were significantly up-regulated and the other three (apoeb, mdm1,
mycl1b) were not significant (p-value.0.1) (Figure S2). The data
suggests that apoeb, mdm1, mycl1b may be more specific to up-
regulation by 17-beta estradiol and BPA. Since mefenamic acid is
to control group (n=4 replicate batches of embryos; each treatment group consisted of 50 embryos). Inset in (A) represents another set of acute
toxicity experiment performed under similar conditions indicating percentage of mortality for developing zebrafish exposed to BPA at 500,
5000,10000, 15000 and 20000 mg/L. Representative samples of zebrafish larvae exposed to: (C) vehicle (control), (D) 50 mg/L, (E) 100, (F) 500, (G) 1500,
and (H) 4500 mg/L, of BPA for 7 days from 3 hpf. Adverse toxic effects was observed at higher frequency in 1500 and 4500 mg/L of BPA which include
cardiac edema (ce), cranio-facial abnormality (cf) and swimbladder (sb) development/inflation problem. Scale bar=500 mm.
doi:10.1371/journal.pone.0028273.g001
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observable phenotype malformation at the concentration used, we
could only infer that ncl1, sp4, U1SNRNPBP homolog were up-
regulated by a different mode of action exerted by mefenamic
acid. This, however, do not negate the significance that these 6
genes are indeed sensitive to perturbation by estrogenic com-
pounds during early life of the zebrafish. The expression of sp4
expression and its role in CNS development and function observed
in rodents [35,36], as well as SP4 association with various
psychiatric disorders in humans [37,38]. The present study
revealed that sp4 expression is a sensitive target of BPA
perturbation, even at relatively low concentration (50 and
Figure 2. Phenotype analysis of BPA early-life exposure toxicity in GFP transgenic fish larvae. (A) Tg(Nkx2.2a-mEGFP) zebrafish larvae
exposed to vehicle (control), 500 mg/L BPA and 5000 mg/L BPA. Panel on the right represent the inset region marked by white-outlined box in the
corresponding left panel. White arrows indicate axon branching which are normal in control fish but marginally and severely affected in fish exposed
to 500 and 5000 mg/L BPA, respectively. (B) ET(krt8-EGFP)
sqet20 zebrafish larvae exposed to vehicle (control), 500 mg/L BPA and 5000 mg/L BPA. Panel
on the right represent the inset region marked by white-outlined box in the corresponding left panel. White arrows indicate neuromast cells which
are rosette circular-like shape in control fish but severely deformed in fish exposed to 500 and 5000 mg/L BPA. (C) Tg(Flia-EGFP)
y1 zebrafish larvae
exposed to vehicle (control), 500 mg/L and 5000 mg/L BPA. White arrow indicate vascularization in abdominal region which is normal in control fish
but suppressed in fish exposed to 500 and (R) 5000 mg/L BPA.
doi:10.1371/journal.pone.0028273.g002
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PLoS ONE | www.plosone.org 5 December 2011 | Volume 6 | Issue 12 | e28273Figure 3. Transcriptomic changes induced by BPA early-life exposure toxicity. (A) Venn-diagrams showing number (percentage) of genes
that were considered significantly deregulated among the three treatment groups (BPA_500 mg/L, BPA_1500 mg/L and BPA_4500 mg/L). B)
Expression profiles of gene probes categorized based on their significant deregulation in one, two and three treatment groups. The colored cells
reflect the mean expression level of four biological replicates in each concentration group when compared to the control (vehicle) group (n=4).
Shades of red cells reflect up-regulated, green cells reflect down-regulated and black cells reflect unchanged, expression levels when compared to
control (vehicle) group.
doi:10.1371/journal.pone.0028273.g003
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PLoS ONE | www.plosone.org 7 December 2011 | Volume 6 | Issue 12 | e28273Figure 5. Connectivity network for common-targeted genes with enriched functional subcategories. The network shows the
connectivity between significantly (Fisher’s Exact Test P,0.05) enriched functional subcategories with the endocrine-regulated human homologs of
zebrafish genes that were commonly deregulated in all the three treatment groups (BPA_500 mg/L, BPA_1500 mg/L and BPA_4500 mg/L). Refer to
Additional Files 6 and 7 for more information.
doi:10.1371/journal.pone.0028273.g005
Figure 4. Transcriptomic analysis and inference of BPA early-life exposure toxicity. Selected top functional sub-categories within (A)
molecular and cellular function, (B) physiological system development and function, (C) disease and disorder, and (D) canonical pathway, which were
all significantly enriched (except for those labeled with asterisk ‘*’where Fisher’s Exact Test P.0.05) with human homologs of zebrafish genes
deregulated in BPA_500 mg/L, BPA_1500 mg/L and BPA_4500 mg/L groups. Refer to Additional Files 2–5 for more information. The figure legend and
Y-axis title for the histogram in (A) are applicable to all other histograms.
doi:10.1371/journal.pone.0028273.g004
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deregulation that could impact brain development, function and
consequently behavior as observed in laboratory animals exposed
to BPA during early life [7,8]. This has been a health-risk concern
expressed by the latest NTP-CERHR expert panel report [6] with
regard to the effects of BPA on the nervous system and behavior as
a result of early life exposure in humans. We are currently doing a
focused study to characterize BPA-induced perturbation of sp4
expression in CNS of zebrafish embryos. Likewise, given the
known association of the corresponding human homolog of the
zebrafish genes such as apoeb with lipid metabolism and
cardiovascular, neurological, reproductive, immune disorders,
mycl1b with cancer, ndgr1 with cancer, reproductive and neuro-
logical disorders, hence chronic early-life deregulation of these
genes warrant further investigations.
Transcriptome analysis and inference of BPA early-life
exposure toxicity
Since human databases have better annotations, and most
available gene expression analysis software do not support
zebrafish data, it is useful to map zebrafish genes to human
homologs for knowledge-based data mining. Moreover, such
mapping would facilitate comparison of fish data with higher
vertebrate data (human/mouse) to capture conservation and to
infer the findings from zebrafish to humans. Therefore, we
mapped the significantly deregulated gene probes from each of the
treatment groups to available corresponding human homologs as
previously described [24] (see Materials and Methods). We were
able to map the 358, 696 and 594 zebrafish genes to 188, 357 and
291 human homologs, respectively, for the 500, 1500 and
4500 mg/L groups. The mapped human homologs of zebrafish
genes were used for knowledge-based data mining via Ingenuity
Pathway Analysis
TM (IPA) software (see Materials and Methods) to
obtain insights into the altered biological functions and signaling
pathways associated with the deregulated genes, as well as for
inferring affected physiological system and potential health-risks.
Based on the Ingenuity database, the algorithm associated 101 (for
500 mg/L), 168 (for 1500 mg/L) and 125 (for 4500 mg/L) of the
human homologs with four primary categories: (i) molecular and
cellular function, (ii) physiological system development and
function, (iii) disease and disorder and (iv) canonical pathway
(Figure 6A–D). Within each primary category, functional sub-
categories which were significantly (Fisher’s Exact Test P,5.0E-
02) enriched with the human homologs of zebrafish genes were
listed (Table S2, S3, S4, S5).
The analysis suggests that molecular and cellular function
associated with cellular assembly and organization, cell death, cell
morphology, small molecule biochemistry, and cell-to-cell signal-
ing and interaction, were among those significantly enriched with
high percentage (9.5%–44%; Fisher’s Exact Test P,2.6E-05 to
3.6E-02) of the human homologs in all three treatment groups
(Figure 6A; complete list in Table S2). Physiological system
development and function related to nervous system was
significantly enriched with the highest percentage (16%–23%;
Fisher’s Exact Test P,3.26E-04 to 3.42E-02) of human homologs
in all three treatment groups, followed by skeletal and muscular
system, cardiovascular system, reproductive system and hemato-
logical system (5%–15%; Fisher’s Exact Test P,1.45E-03 to
3.24E-02) (Figure 6B, Table S3). Likewise, neurological disease,
reproductive system disease, skeletal muscular disorder, and
cardiovascular disease were also significantly enriched with
relatively high percentage (4%–16%; Fisher’s Exact Test
P,2.48E-04 to 3.6E-02) of human homologs in all three treatment
groups in the ‘disease and disorder’ category (Figure 6C, Table
S4).
In addition, we were able to capture deregulated signaling
pathways (Figure 6D, Table S5) that could be associated with
the affected cellular functions, physiological systems and pheno-
type. Specifically, signaling pathways involved in tight junction,
actin cytoskeleton, integrin, clathrin-mediated endocytosis, Nrf2-
mediated oxidative stress and ephrin receptor were significantly
(Fisher’s Exact Test P,0.05) deregulated by BPA exposure which
are known to be associated with cellular death/survival,
differentiation, morphology, movement and intercellular signaling.
Pathways associated with tight junction, integrin and cytoskeletal
actin signaling can modulate cell morphology and motility [39,40]
while deregulation of ephrin receptor signaling is known to affect
axon guidance, cardiovascular, skeletal-muscular and craniofacial
development [41,42] as observed in this study. Deregulation of
synaptic long-term potentiation and clathrin-mediated endocytosis
which affects synaptic transmission [43], coupled with ephrin
receptor and axonal guidance are likely associated with the
abnormal neurological phenotypes such as suppressed neuron
branching observed in Tg(Nkx2.2a-mEGFP), abnormal neuromast
cells in ET(krt8-EGFP)
sqet20 and poor tactile response and
abnormal swimming behavior in wildtype zebrafish that were
exposed to higher levels of BPA. Moreover, deregulation of
signaling pathways involving ephrin receptor, clathrin-mediated
endocytosis, integrin and tight junction together with VEGF
signaling [44,45] may be linked with the cardiac edema and
suppressed vascularization in the abdominal region as observed in
wildtype and/or transgenic Tg(Flia-EGFP)
y1 exposed to higher
levels of BPA. While we could infer association with specific
signaling pathways based on deregulated genes and phenotypes
observed in the study, it would not be possible to know if a
deregulated signaling pathway is a cause or an effect of a
phenotype. Future studies for both short and long BPA exposures
will be required to link the specific pathways in primary response
to secondary responses.
Common targeted-genes underlying BPA early-life
exposure toxicity
To further understand the common underlying molecular
targets and mechanisms, we examined the biological functions
and associations of the 73 common targeted-genes that were
deregulated in all the three treatment groups. This group of
common targeted-genes deserves special attention as they were
consistently deregulated by BPA from low to high concentration.
We were able to map the 73 genes to 38 human homologs
whereby gene ontology annotation indicates that the protein they
encode include 11 enzymes, 5 transporters, 4 transcription
regulators, 2 signal transducers, 1 transmembrane receptor and
1 structural protein while the remaining 14 have functions that are
not well-defined, hence categorized as ‘others’ (Table 1).
Interestingly, 11 (29%) of the human homologs encoding
ACADM, BLNK, CPA2, HSD17B8, NDRG1, RND3, SSR2,
SLC34A2, and transcription regulators EGR2, GABPA, SP4 have
been reported to be regulated by estrogen, and 3 (8%) of the
human homologs encoding LRRC4, SLC34A2 and transcription
regulator GABPA have been reported to be regulated by thyroid
hormone (see references within Table S6). Another human
homolog encoding transcription regulator ZNF384/NM4 is
known to be regulated by parathyroid hormone. Notably, human
homolog encoding HSD17B8 known for its key involvement in
androgen and estrogen metabolism was down-regulated hence
further amplifying the endocrine disruptive effects on the
development of reproductive organs and sexual maturation. The
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PLoS ONE | www.plosone.org 9 December 2011 | Volume 6 | Issue 12 | e28273Figure 6. Real-time PCR validation of selected up-regulated zebrafish genes. Using samples from a separate validation experiment (n=5–6
biological replicates; each replicate consist of five pooled larvae), selected up-regulated genes were validated by real-time PCR and compared with
corresponding microarray data. Axis titles on the upper left histogram and figure legends are applicable to all histograms.
doi:10.1371/journal.pone.0028273.g006
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mediated through the targeting of endocrine-regulated genes
which could be captured by zebrafish whole-animal toxicoge-
nomics. While it is known that BPA disrupt estrogen and thyroid
hormones signaling [46], this study identified a set of endocrine-
regulated genes operating during early life development, previ-
ously not known to be disrupted by BPA. Although a number of
estrogen-regulated genes were identified, canonical estrogen
receptor signaling pathway was not enriched in our analysis.
The reason could be estrogen signaling occurs at the upstream
Table 1. Human homolog of zebrafish genes (38) that were significantly deregulated in all three BPA exposed groups (500 mg/L,
1500 mg/L and 4500 mg/L).
Gene Symbol [Description] Mean Fold-Change (Log2 Ratio)
a Function Endocrine-regulated
b
CSRP2BP [CSRP2 binding protein]* 0.98 others
NCLN [nicalin]* 0.88 enzyme (peptidase)
U1SNRNPBP [U11/U12 snRNP]* 0.86 others
ETFA [electron-transfer-flavoprotein, alpha polypeptide] 0.68 transporter
MRPS9 [mitochondrial ribosomal protein S9] 0.67 others
MDM1 [Transformed 3T3 cell double minute 1]* 0.61 others
ATP5F1 [ATP synthase, F0 complex, subunit B1]* 0.57 transporter
CAMK2D [CaM kinase II delta]* 0.55 enzyme (kinase)
ZNF384 [zinc finger protein 384; CIZ/Nmp4]* 0.54 transcription regulator Parathyroid
TRAM2 [translocation associated membrane protein 2] 0.52 transporter
METAP1 [methionyl aminopeptidase 1] 0.45 enzyme (peptidase)
EGR2 [early growth response 2; Krox20]* 0.44 transcription regulator E2
SP4 [specificity protein 4]* 0.41 transcription regulator E2
GABPA [GA binding protein transcription factor,
alpha subunit; NRF2a]*
0.38, 20.43
c transcription regulator Thyroid and E2
AXIN1 [axin 1] 20.22, 0.20
d signal transducer
FEM1B [fem-1 homolog b] 20.36 others
FIP1L1 [FIP1 like 1] 20.38 others
RND3 [Rho family GTPase 3] 20.38 enzyme (GTPase) E2
MOSPD1 [Motile sperm domain containing 1] 20.40 others
MID1IP1 [MID1 interacting protein 1] 20.42 others
YIPF1 [Yip1 domain family, member 1]* 20.43 transporter
SRPX [sushi-repeat-containing protein, X-linked] 20.46 others
LIM2 [lens intrinsic membrane protein 2]* 20.46 others
BLNK [B-cell linker] 20.46 signal transducer E2
HSD17B8 [hydroxysteroid (17-beta) dehydrogenase 8]* 20.48 enzyme (metabolic) E2 and E2 metabolism
LRRC4 [leucine rich repeat containing 4] 20.52 others Antithyroid
(Propylthiouracil)
ACTG1 [actin, gamma 1] 20.52 structural protein
CPA2 [carboxypeptidase A2 (pancreatic)] 20.56 enzyme (peptidase) E2
XRN2 [59-39 exoribonuclease 2] 20.57 enzyme (nuclease)
PCID2 [PCI domain containing 2] 20.58 others
SLC34A2 [solute carrier family 34, member 2; NAPI2] 20.59 transporter E2 and Thyroid
SH2D5 [SH2 domain containing 5] 20.61 others
CD74 [CD74 major histocompatibility complex] 20.61 transmembrane receptor
NDRG1 [N-myc downstream regulated 1]* 20.62 enzyme (kinase) E2
PRSS33 [protease, serine, 33] 20.69 enzyme (peptidase)
POP5 [processing of precursor 5] 20.70 enzyme (nuclease)
SSR2 [signal sequence receptor, beta] 20.74 others E2
ACADM [acyl-Coenzyme A dehydrogenase; MCAD]* 20.80 enzyme (metabolic) E2
*the zebrafish genes were subsequently validated using real-time PCR on a new batch of fish.
aaverage expression fold-change above control (log2 ratio) for 500 mg/L, 1500 mg/L and 4500 mg/L BPA (microarray data).
brefer to Table S6 for references reporting on the endocrine regulation of the genes.
cup-regulated at 500 mg/L but down-regulated at 1500 mg/L and 4500 mg/L BPA (microarray data).
ddown-regulated at 500 mg/L but up-regulated at 1500 mg/L and 4500 mg/L BPA (microarray data).
doi:10.1371/journal.pone.0028273.t001
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downstream effects of estrogen signaling at the transcriptome level.
This was evident as many estrogen responsive genes are not part of
the canonical estrogen-receptor signaling pathway but rather
downstream of it. Moreover, BPA has been shown to act weaker
(at least 1000-fold weaker than estradiol) on the classical genomic
estrogen receptor signaling pathway compared to its non-genomic
estrogenic actions [47–49], therefore if there is any deregulation of
the canonical estrogen receptor signaling pathway at the
transcriptome level, the signals may be too weak and masked by
stronger downstream signals. It is also worth highlighting that 39%
(15/38) of the common deregulated genes (Table 1) including
64% (7/11) of them used in the subsequent network analysis were
validated by real-time PCR in an independent experiment
(Figure 4 and 5).
Inference of molecular mechanism underlying BPA early-
life exposure toxicity via network connectivity analysis
We submitted the 38 human homologs that were deregulated in
all the treatment groups for Ingenuity Pathway Analysis
TM and the
algorithm identified 23 of the homologs to be significantly
associated with the analysis. Using only the known endocrine-
regulated homologs and their associations with the functional
subcategories (see Table S7), a network was generated to visualize
their connectivity and to further understand how these targeted
genes could have associated with BPA early-life exposure toxicity
(Figure 7). Among the four transcription regulators, EGR2
connected to 19 functional subcategories, has the highest
connectivity involving various cellular functions (cell death,
cellular growth and proliferation, cellular organization and
assembly, cellular movement and development, cell and tissue
morphology) in several physiological tissues/systems (nervous,
hematological, immune and reproductive systems and cancer cells)
suggesting vast biological role/impact of this deregulated gene (see
references within Table S7). Transcription regulator SP4 is
connected to 7 subcategories involving cellular organization and
assembly, cell and tissue morphology which are associated with
nervous system development (patterning and remodeling of
neurons) and neurological degenerative disease (Figure 7; Table
S7). SP4 is also required for development of the cardiac
conduction system hence associated with cardiovascular disease
(sinus bradycardia and ventricular tachycardia). The up-regulation
of both EGR2 and SP4 by estrogen had been shown to be mediated
by phosphatidylinositol 3-phosphate (PI3K) in a non-genomic
manner [50]. More recent reports indicated that BPA could also
exert its estrogenic activity via non-genomic mechanism [47–49].
Taken together, this suggests that the up-regulation of these two
transcription regulators may be induced by BPA via PI3K in a
non-genomic manner. Transcription regulator GABPA, connect-
ed to 6 subcategories involved in cell death, cell morphology and
cell to cell signaling and interaction, is required for structural
formation and function of neuromuscular junctions in skeletal
muscle hence its association with the development and function of
nervous, skeletal and muscular systems (Figure 4; Table S7).
Estradiol treatment has been reported to down-regulate GABPA
[51] and the down-regulation of zebrafish gabpa at 1500 ug/L and
4500 ug/L BPA observed in our study may be attributed to the
estrogenic activity of BPA although the actual mechanism of this
down-regulation is still not clear. Transcription regulator ZNF384
homolog is a nucleocytoplasmic shuttling protein which regulates
the expression of collagen and matrix metalloproteinases impor-
tant for bone development and is also required for spermatogen-
esis, hence its association with the development and function of
skeletal, muscular and reproductive systems (Figure 4; Table
S7). Estradiol and/or BPA are known to affect spermatogenesis
[52] and bone development [53] although it is not clear how
ZNF384 is up-regulated by BPA in these processes which therefore
warrant further focused investigation.
Among the ‘Molecular and Cellular Function’ subcategories,
‘Cell Death’ (connected with GABPA, EGR2, NDRG1, RND3,
BLNK) and ‘Cell Morphology’ (connected with EGR2, NDRG1,
RND3, BLNK, and SP4) had the highest (5) connectivity
(Figure 4). Based on the known developmental functions of these
genes, cell death and cell morphological changes may be largely
occurring in the nervous, blood/immune and reproductive
systems. Nervous system (connected with EGR2, GABPA,
LRRC4 and SP4) and reproductive system (connected with
EGR2, HSD17B8, NDRG1 and ZNF384 homolog), had the
highest (4) connectivity among the ‘physiological system develop-
ment and function’ category suggesting that these organ-systems
are likely to be impacted developmentally by BPA. Cancer
(connected with EGR2, LRRC4, NDRG1 and BLNK2) and
neurological disease (connected with EGR2, LRRC4, NDRG1
and SP4) has the highest (4) connectivity suggesting increased risk
or susceptibility to these conditions in BPA-treated developing fish.
Taken together, the analysis reveals that BPA early-life exposure
toxicity involved deregulation of endocrine-regulated genes with
multiple roles in gene expression, signaling, transportation,
enzymatic functions that regulates cellular functions (e.g. cell
death, cell morphology, and cell differentiation) and development
of several organ systems (nervous, reproductive and blood/
immune systems being most vulnerable). This in turn may lead
to increased risk of related diseases/disorders. Several of these
affected physiological systems (nervous, cardiovascular, blood,
reproductive, skeletal and muscular) and potential health impact
have been either demonstrated in vitro and/or in rodents exposed
to BPA or more potent estrogenic compounds [7–9,47,54,55].
Specifically, it has been established that prenatal and/or neonatal
exposure to low doses of BPA causes organizational changes in the
reproductive tissues (prostate, breast, testis, mammary glands),
body size, brain structure and chemistry, and behavior of
laboratory animals that persist to adulthood, long after the period
of exposure has ended [7,8]. There is also evidence that BPA
modulates the immune system [7] and may be associated with
increased cancer of the hematopoietic and reproductive systems
[9].Therefore, our findings are in line with the evidence of BPA
adverse effects in laboratory animal studies and the concerns
expressed by the latest NTP-CERHR expert panel report [6] with
regard to the effects of BPA on the nervous system and behavior as
well as reproductive tissues, in fetuses, infants, and children that
are expose to BPA. Even so, these are inferences made based on
association hence conclusive links and roles of these genes with
BPA and the phenotypes observed would require more focused
study on these genes in rodent or even appropriate in vitro cell
lines. It will be interesting to investigate if similar mode-of-action is
also associated with the adverse effects on nervous, reproductive
and blood/immune systems reported in rodent studies [7,8].
Conclusion and Future Studies
The present study provided molecular insights into BPA early-
life exposure toxicity in zebrafish involving disruption of
endocrine-regulated gene expression and other signaling path-
ways that are known to play important roles in the development
of tissue-organs, especially nervous, reproductive, cardiovascular,
skeletal-muscular and blood systems. The findings corroborated
with those reported in rodent studies in terms of BPA exerting
endocrine disrupting effects and BPA affected organ-tissues,
especially on the nervous, reproductive and blood systems. Even
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PLoS ONE | www.plosone.org 12 December 2011 | Volume 6 | Issue 12 | e28273Figure 7. Real-time PCR validation of selected down-regulated zebrafish genes. Using samples from a separate validation experiment
(n=5–6 biological replicates; each replicate consist of five pooled larvae), selected down-regulated genes were validated by real-time PCR and
compared with corresponding microarray data. Axis titles on the upper left histogram and figure legends are applicable to all histograms.
doi:10.1371/journal.pone.0028273.g007
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many differing factors (e.g. physiology, life stages, mode and
duration of exposure). Future studies involving absorption,
distribution, metabolism and excretion (ADME) profile of BPA
in developing zebrafish may help to generate scaling factors that
could facilitate comparison and in vivo-in vivo correlation between
the zebrafish and rodent models, or perhaps even humans.
Nevertheless, this study demonstrated the potential of using
zebrafish as a model for toxicogenomic inference of early-life
exposure toxicity through BPA-induced cumulative phenotype
and transcriptome analyses. Our findings revealed that zebrafish
toxicogenomics could capture molecular information involving
genes and signaling pathways that are useful to infer affected
development and function of physiological systems as well as
potential health-risks. Even so, we must stress that judicial
interpretation is still required and while corroboration with
phenotypic data could strengthen the analysis, a focused study on
related genes is still required to be conclusive. Nevertheless, from
the perspective of toxicity and hazard inference during early
screening of compounds, such toxicogenomic information
coupled with phenotypic data could serve well to alert
investigators of a compound’s potential health liabilities and
provide needed information to conduct focused studies to
investigate its specific toxicity. Finally, through this study we
were able to identify a set of endocrine-regulated genes operating
during early-life of zebrafish that are sensitive to BPA
perturbation. These genes can serve as biomarkers or targets
for more focused investigations such as kinetic studies with
multiple time-point samplings or for mechanistic studies. Since
the approach presented here is applicable to other typical
compounds, our findings will place zebrafish in a strategic
position for toxicogenomics application in early-life toxicity
testing and as hazard indicator of various compounds. This is
significant in view that there are strong demands and advocates
for using zebrafish as an alternative model for evaluating the
toxicity of pharmaceuticals, industrial chemicals and effluents by
regulators and industry.
Materials and Methods
Ethics statement
All experimental protocols were approved by Institutional
Animal Care and Use Committee (IACUC) of National University
of Singapore (Protocol 079/07).
BPA exposure and fish sampling
Three types of experiments were performed in this study, i.e.
general acute toxicity tests, microarray experiment and PCR
biomarker validation experiment. Experimental procedures were
performed within the guidelines of National University of
Singapore’s Institutional Animal Care and Use Committee
(NUS-IACUC). Different batches of developing zebrafish were
exposed to BPA (Sigma-Aldrich, USA) at nominal concentrations
between 50–5000 mg/L with 0.05% ethanol (vehicle) in egg water.
In the acute toxicity test and PCR biomarker validation
experiments, developing zebrafish were exposed to 50, 100, 500,
1500 and 4500 mg/L BPA for 7 days from 3 hour post-fertilization
onwards while in the microarray experiment, developing zebrafish
were exposed to 500, 1500 and 4500 mg/L BPA for the same
duration. In experiments involving transgenic fish, exposure were
carried out at 50, 500, and 5000 mg/L BPA for 5 days from 3 hour
post-fertilization onwards. All control fish were maintained in egg
water with 0.05% ethanol (vehicle). The developing zebrafish were
maintained at an ambient temperature of about 2661uCi na
static condition and fresh media were renewed daily. At the end of
the experiments, fish were examined for various phenotypic end-
points, or snap-frozen in liquid nitrogen and stored at 280uC for
total RNA extraction for microarray and PCR biomarker
validation experiments.
Total RNA extraction
Total RNA was extracted from 50 pooled larvae for each group
using Trizol reagent (Invitrogen, USA) according to the manu-
facturer’s instructions. Reference RNA for microarray hybridiza-
tion was obtained by pooling zebrafish whole adult male and
female total RNA at 9:1 ratio. The integrity of RNA samples was
verified by gel electrophoresis, and the concentrations were
determined by UV spectrophotometer.
Microarray hybridization
The arrays contained 22K oligonucleotide probes where 16.4K
probes were designed by Compugen (USA) and the remaining
probes were in-house designed by the bioinformatics group in
Genome Institute of Singapore (GIS). The probes were resus-
pended in 36SSC at 20 mM concentration and spotted onto in-
house poly-L-lysine-coated microscope slides using a custom-built
DNA microarrayer in GIS.
A common reference design is used where equal amount of total
RNA from control or BPA-treated groups were labeled with Cy5
and co-hybridized with equal amount of common pooled
reference RNA labeled with Cy3 for each array. Hence, for
fluorescence labeling of cDNAs, 10 mg of total RNA from the
reference and samples (treated and control groups) were reverse
transcribed in the presence of dNTPs mixed with Aminoallyl-
dUTP (Sigma-Aldrich, USA) followed by coupling with mono-
functional NHS-ester Cy3 and Cy5 dyes (Amersham, USA),
respectively. The respective paired Cy5- and Cy3-labeled cDNAs
were pooled, concentrated, and resuspended in DIG EasyHyb
(Roche Applied Science) buffer for hybridization on a single array
at 42uC for 16 h in a hybridization chamber (MAUI, USA). After
hybridization, the array-slides were washed in a series of washing
solutions (26SSC with 0.1% SDS, 16SSC with 0.1% SDS, 0.26
SSC and 0.056 SSC; 30 sec each), dried using low-speed
centrifugation, and scanned for fluorescence detection.
Data acquisition, normalization and statistical filtering
The arrays were scanned using the GenePix 4000B microarray
scanner (Axon Instruments, USA) and the generated images with
their fluorescence signal intensities were analyzed using GenePix
Pro 4.0 image analysis software (Axon Instruments, USA). Only
gene features that were not flagged were extracted and subjected
to Lowess normalization for further analyses. The microarray raw
data have been formatted to be compliant with MIAME standard
and has been submitted to GEO database (GEO Number:
GSE22634).
Since a common reference design was used in our two-color
array experiment, it allows for direct comparison of expression
data between the treatment and control groups (n=4 replicates).
An initial One-Way ANOVA was applied on the Lowess-
normalized data to narrow down genes that were differentially
expressed and the resulting P-value of each gene was adjusted for
Benjamini and Hochberg False Discovery Rate (FDR). To further
obtain significant probes in each of the treatment group compared
with the control group, Student’s t-test was applied between the
treatment and the control groups on the 20% FDR-selected
dataset. Estimates of fold change were calculated, and genes with
P-value,0.05, were considered for further analysis.
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data mining
To obtain insights into the biological functions and for health-
risk inferences in humans, the zebrafish genes were mapped to
their corresponding human homologs using the GIS Zebrafish
Microarray Annotation Database (http://123.136.65.67/) as
previously described [24]. National Center for Biotechnology
Information (NCBI, USA) HomoloGene and UniGene databases
were used for human homology mapping of the zebrafish genes.
HomoloGene allows for detection of putative homologs among the
annotated genes of several eukaryotic genomes and has links to
UniGene clusters established by tblastn search of the UniGene
database. The latest UniGene and HomoloGene Build files were
downloaded from the following sites ftp://ftp.ncbi.nih.gov/
repository/UniGene/Danio_rerio/ and ftp://ftp.ncbi.nlm.nih.
gov/pub/HomoloGene/ , respectively. A PERL script was written
to map all zebrafish UniGene clusters to human UniGene clusters
that are identified as homologs of each other by the HomoloGene
database. Another PERL script was written to enable automated
mapping of GenBank Identifiers (GenBank Accession Number) of
the zebrafish probes on the array to their respective UniGene
cluster which are then mapped to human UniGene cluster(s) that
has been identified as homolog(s) by HomoloGene database. This
automated procedure is part of the Genome Institute of Singapore
Zebrafish Microarray Annotation Database and is updated
periodically from several resource databases.
The human homologs of the zebrafish genes from the filtered
dataset were used to mine the human database via Ingenuity
Pathway Analysis
TM software (www.ingenuity.com). The software
identifies three primary categories of functions, (i) molecular and
cellular function, (ii) physiological system development and
function, and (iii) disease and disorder, whereby each category is
further subdivided into multiple levels of functional subcategories
that are significantly enriched with human homologs of zebrafish
genes from the input dataset. A right-tailed Fisher’s Exact test was
used to calculate P-values in determining the probability that each
functional category enriched with the human homologs hence its
association with the dataset is due to chance alone. P,0.05 is
considered significant by the algorithm suggesting that the
association is non-random. A network limited to the endocrine-
regulated genes that are significant in all the treatment groups is
generated by maximizing the specific connectivity of the mapped
human homologs with other enriched functional subcategories.
Biomarker validation using real-time PCR
To validate the microarray data, two independent validation
experiments were carried out from new batches of developing
zebrafish similar to the earlier acute toxicity experiment (n=5–6
biological replicates; each biological replicate consists of five
pooled larvae). Equal amounts of total RNA samples were reverse
transcribed to cDNA (Invitrogen, USA). The cDNA samples were
used for quantitative real-time PCR analysis, performed using the
Lightcycler system (Roche Applied Science) with Lightcycler-
FastStart DNA Master SYBR Green 1 (Roche Applied Science)
according to the manufacturer’s instructions. Statistical compar-
ison of the relative mean expression level for each gene between
test and control groups was performed using Student’s T-test and
P,0.05 is considered significant. Estimate of fold change (log2)
between each treatment group and control group were presented.
Supporting Information
Figure S1 Inhibition of axon growth and branching was
observed in Tg(Nkx2.2a-mEGFP) line treated with 17-
beta estradiol (E2 at 10, 50, 100 mg/L) but not with
mefenamic acid (MA at 10, 50, 100 mg/L) when com-
pared to control group.
(TIF)
Figure S2 Real-time PCR validation of the six genes
(ncl1, apoeb, mdm1, mycl1b, sp4, U1SNRNPBP homolog)
using samples from wildtype developing zebrafish
treated with 17-beta estradiol [E2 at 10 mg/L
(36.7 nM), 50 mg/L (183.5 nM), 100 ug/L (367.1 nM) ],
mefenamic acid [MA at 10 mg/L (41.4 nM), 50 mg/L
(207.0 nM), 100 mg/L(414.4 nM)] and Bisphenol A [BPA
at 50 mg/L (207.0 nM), 100 mg/L(438.0 nM)]. Numbers in
the cell indicate mean expression levels (log2 fold-change) above
control group (n=5–6).
(TIF)
Table S1 Information of zebrafish transgenic lines used
in present study.
(PDF)
Table S2 Selected top functional subcategories of
‘Molecular and cellular function’ that are significantly
enriched with human homologs of zebrafish genes
deregulated by 500 mg/L, 1500 mg/L and 4500 mg/L of
BPA.
(PDF)
Table S3 Selected top functional subcategories of
‘Physiological system development and function’ that
are significantly enriched with human homologs of
zebrafish genes deregulated by 500 mg/L, 1500 mg/L
and 4500 mg/L of BPA.
(PDF)
Table S4 Selected top functional subcategories of
‘Disease and disorder’ that are significantly enriched
with human homologs of zebrafish genes deregulated by
500 mg/L, 1500 mg/L and 4500 mg/L of BPA.
(PDF)
Table S5 Selected top functional subcategories of
‘Canonical Pathways’ that are significantly enriched
with human homologs of zebrafish genes deregulated by
500 mg/L, 1500 mg/L and 4500 mg/L of BPA.
(PDF)
Table S6 Human homolog of zebrafish genes that were
significantly deregulated in all three BPA exposed
groups (500 mg/L, 1500 mg/L and 4500 mg/L).
(PDF)
Table S7 Selected functional subcategories that are
significantly (Fisher’s Exact Test P,0.05) enriched with
human homologs of zebrafish genes deregulated in all
BPA treatment groups (500 mg/L, 1500 mg/L and
4500 mg/L).
(PDF)
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